Back to Search Start Over

QSAR and Classification of Murine and Human Soluble Epoxide Hydrolase Inhibition by Urea-Like Compounds

Authors :
McElroy, N. R.
Jurs, P. C.
Morisseau, C.
Hammock, B. D.
Source :
Journal of Medicinal Chemistry; March 2003, Vol. 46 Issue: 6 p1066-1080, 15p
Publication Year :
2003

Abstract

A data set of 348 urea-like compounds that inhibit the soluble epoxide hydrolase enzyme in mice and humans is examined. Compounds having IC<INF>50</INF> values ranging from 0.06 to >500 μM (murine) and 0.10 to >500 μM (human) are categorized as active or inactive for classification, while quantitation is performed on smaller compound subsets ranging from 0.07 to 431 μM (murine) and 0.11 to 490 μM (human). Each compound is represented by calculated structural descriptors that encode topological, geometrical, electronic, and polar surface features. Multiple linear regression (MLR) and computational neural networks (CNNs) are employed for quantitative models. Three classification algorithms, k-nearest neighbor (kNN), linear discriminant analysis (LDA), and radial basis function neural networks (RBFNN), are used to categorize compounds as active or inactive based on selected data split points. Quantitative modeling of human enzyme inhibition results in a nonlinear, five-descriptor model with root-mean-square errors (log units of IC<INF>50</INF> [μM]) of 0.616 (r<SUP>2</SUP><SUP></SUP> = 0.66), 0.674 (r<SUP>2</SUP><SUP></SUP> = 0.61), and 0.914 (r<SUP>2</SUP><SUP></SUP> = 0.33) for training, cross-validation, and prediction sets, respectively. The best classification results for human and murine enzyme inhibition are found using kNN. Human classification rates using a seven-descriptor model for training and prediction sets are 89.1% and 91.4%, respectively. Murine classification rates using a five-descriptor model for training and prediction sets are 91.5% and 88.6%, respectively.

Details

Language :
English
ISSN :
00222623 and 15204804
Volume :
46
Issue :
6
Database :
Supplemental Index
Journal :
Journal of Medicinal Chemistry
Publication Type :
Periodical
Accession number :
ejs4356119